Delivery Order SPE2DE21D7020-SPE2D625F0YXE
- Not listed
- Boston Scientific Corp, headquartered in Marlborough, Massachusetts, was awarded a fixed-price delivery order valued at $7,593.10 by the Defense Health Agency's Medical Supply Chain on August 20, 2025, with an ultimate completion date of August 27, 2025. The contract involves the supply of enroute TCAR (transcarotid artery revascularization) stents, specialized cardiovascular intervention devices used in minimally invasive procedures. This delivery order was competitively awarded with no...
- Boston Scientific Corp was awarded a delivery order valued at $3,326.30 by the Defense Health Agency's Medical Supply Chain for enroute TCAR stents, with performance in Marlborough, MA. The contract was awarded on August 12, 2025, with an ultimate completion date of August 19, 2025, and utilizes fixed-price pricing with economic price adjustment. This is an open competition award with no set-aside designation, allowing Boston Scientific to compete directly against other qualified vendors in...
- Boston Scientific Corp has been awarded a delivery order valued at $11,389.65 for enroute TCAR stents under a Defense Health Agency Medical Supply Chain contract. The award, issued on September 2, 2025, with an ultimate completion date of September 9, 2025, represents a fixed-price contract with economic price adjustment provisions. The work will be performed at Boston Scientific's facility in Marlborough, Massachusetts. No set-aside designation was applied to this award, indicating open...
- The Defense Health Agency's Medical Supply Chain awarded a delivery order valued at $3,326.30 to Boston Scientific Corp for EnRoute TCAR stents on July 25, 2025, with an ultimate completion date of August 1, 2025. This fixed-price contract with economic price adjustment carries no set-aside designation, allowing Boston Scientific to compete openly in the federal marketplace. The work will be performed at Boston Scientific's facility in Marlborough, Massachusetts, where the company manufactures...
- This federal contract award was issued by the Defense Health Agency (DHA) to Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts. The $3,796.55 fixed-price with economic price adjustment delivery order contract is for the provision of ENROUTE TCAR STENTS, which are specialized medical devices used in cardiovascular procedures. The contract has an ultimate completion date of July 16, 2025 and was awarded on July 9, 2025. It is not designated...
- This is a federal contract award to Boston Scientific Corp, a global medical technology company, by the Veterans Integrated Service Network 4 (VISN 4), a division of the U.S. Department of Veterans Affairs (VA). The contract is for the delivery of TCAR stents, a type of cardiovascular medical device, with a ceiling value of $94,179.00. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of October 3, 2025. The award was made on August 29,...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, was awarded a delivery order valued at $13,027.08 by the Defense Health Agency's Medical Supply Chain on August 4, 2025. The contract, which utilizes fixed-price pricing with economic price adjustment, is scheduled for completion by August 11, 2025. The award represents a non-set-aside competitive procurement, and the place of performance is Boston Scientific's facility in Marlborough, MA. As...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $8,234.04 for a 5mm catheter with 150cm length and 200mm range, translating to transvascular or transluminal technology. The contract, awarded on September 11, 2025, with an ultimate completion date of September 18, 2025, utilizes fixed price with economic price adjustment pricing and carries no set-aside designation. The Defense Health Agency's...
- Boston Scientific Corp, a leading global medical technology company headquartered in Marlborough, Massachusetts, was awarded a delivery order valued at $15,482.76 for the ENROUTE NPS Plus product under the Defense Health Agency's Medical Supply Chain contract. This fixed-price delivery order with economic price adjustment capability was issued on September 10, 2025, with an ultimate completion date of September 17, 2025. The contract was awarded on an open, competitive basis with no set-aside...
- Boston Scientific Corp, a leading global medical technology company headquartered in Marlborough, Massachusetts, was awarded a delivery order valued at $2,157.35 by the Defense Health Agency's Medical Supply Chain on August 19, 2025. The contract covers a Selective MC Single Bern 130CM medical device and carries an ultimate completion date of August 26, 2025. This fixed-price delivery order with economic price adjustment represents one of numerous federal contract awards Boston Scientific...
- SPE2DE21D7020Indefinite Delivery Contract
- SPE2DE21D7020-SPE2D625F0YXEDelivery Order
Boston Scientific Corp, a leading global medical technology company headquartered in Marlborough, Massachusetts, was awarded a delivery order valued at $7,593.10 for EnRoute TCAR stents on August 14, 2025. This fixed-price contract with economic price adjustment is scheduled for ultimate completion by August 21, 2025, and will be performed at Boston Scientific's Marlborough facility. The award is being funded through the Defense Health Agency's Medical Supply Chain, a defense-focused federal program supporting critical medical device procurement across the Department of Defense healthcare system. No set-aside designation was applied to this competitive award. This delivery order represents a component of Boston Scientific's broader federal contracting relationship with the Defense Health Agency, through which the company serves as a primary supplier of specialized cardiovascular and interventional medical devices. TCAR (Transcarotid Artery Revascularization) stents are advanced cardiovascular intervention tools used in minimally invasive procedures to treat carotid artery disease. Boston Scientific's extensive portfolio of federal contracts demonstrates its critical role in supplying specialized medical technologies, including stents, catheters, and diagnostic equipment, to federal healthcare agencies including the Veterans Affairs system and Defense Logistics Agency.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.6k | 8/14/25 |